Brief: Calmark Says Developing POC-Test To Help Assess Disease Severity For Patients With COVID-19 Patients

Calmark Sweden AB

25/06/2020 22:54

June 25 (Reuters) - Calmark Sweden AB  CALMAb.TE :
    * CALMARK IS DEVELOPING A POC-TEST TO HELP ASSESS DISEASE SEVERITY FOR PATIENTS WITH
COVID-19
PATIENTS
    * CALMARK SWEDEN - TO PRIORITIZE DEVELOPMENT OF A DIAGNOSTIC POINT-OF-CARE TEST FOR LACTATE
DEHYDROGENASE BIOMARKER AIMED AT ADULT PATIENTS WITH COVID-19
    * CALMARK SWEDEN - LACTATE DEHYDROGENASE BIOMARKER HAS BEEN SHOWN IN SEVERAL STUDIES TO BE
HELPFUL
IN DETERMINING PROGNOSIS IN PATIENTS WITH COVID-19

Source text for Eikon:  ID:nWkrVdpWp 
Further company coverage:  CALMAb.TE 

 ((Reuters.Briefs@thomsonreuters.com;))